Key Takeaways
Strep throat, caused by group A Streptococcus, is typically a mild bacterial infection that responds well to antibiotics. Complications are uncommon but can include abscesses, ear infections, sinusitis, and rheumatic fever. Very rarely, infection spreads to cause severe invasive diseases such as necrotizing fasciitis or streptococcal toxic shock syndrome, which can be life-threatening. Most deaths are associated with delayed or absent treatment, underlying health conditions, or specific virulent strains.
What Is Strep Throat?
Strep throat is an infection of the throat and tonsils caused by group A Streptococcus bacteria. It spreads through respiratory droplets or direct contact with infected respiratory secretions. Common symptoms include sudden sore throat, fever, swollen lymph nodes, and white patches on the tonsils. Symptoms often appear one to five days after exposure. Rapid antigen detection tests and throat cultures are used to confirm the diagnosis.
Overview of Complications
Most people with strep throat recover fully with appropriate antibiotics. However, untreated or inadequately treated infections can lead to local complications and, in rare cases, systemic illness.
Local Complications
Local complications involve nearby tissues and structures. They may include peritonsillar abscess (quinsy), cellulitis of the neck, ear infections, and sinusitis. Symptoms can include severe unilateral throat pain, difficulty opening the mouth, muffled voice, and swelling. These complications usually require drainage and continued antibiotics.
Post-Streptococcal Sequelae
Rheumatic fever and post-streptococcal glomerulonephritis are immune-mediated complications that can occur after strep throat. Rheumatic fever most commonly affects the heart, joints, skin, and brain and is rare in regions with prompt antibiotic use. Acute glomerulonephritis involves kidney inflammation and may cause swelling, dark urine, and elevated blood pressure.
Invasive Group A Streptococcal Disease
Invasive group A Streptococcus (iGAS) occurs when bacteria invade normally sterile sites such as blood, muscles, or lungs. Risk factors include age extremes, chronic illness, immunosuppression, skin infections, and recent viral infections like influenza. iGAS can cause severe conditions including necrotizing fasciitis, streptococcal toxic shock syndrome, pneumonia, and bacteremia. Outcomes depend on prompt recognition and aggressive treatment.
Severity and Fatality
While most strep throat cases are mild and non-fatal, invasive infections can be life-threatening. Case fatality rates vary by pathogen, host factors, and timeliness of care. Early diagnosis and appropriate antibiotics reduce the risk of severe outcomes. Mortality is more closely linked to delayed care, comorbidities, and specific strain characteristics than to strep throat alone.
Who Is at Higher Risk
Certain groups have a higher likelihood of complications from strep throat or related infections.
Children and Older Adults
Children, especially those aged 5 to 15, are most commonly affected by strep throat. Older adults, particularly those with chronic conditions, are at increased risk of complications and invasive disease.
People With Weakened Immune Systems or Chronic Illness
Conditions such as diabetes, kidney disease, HIV, and immunosuppressive therapy can increase susceptibility to severe infection and poor outcomes.
Delays in Seeking Care
Avoiding medical attention or delaying antibiotic treatment can raise the risk of complications and progression to invasive disease.
Clinical Evidence and Surveillance Data
Global and national surveillance programs monitor trends in strep throat, antibiotic resistance, and invasive GAS disease. Data indicate low case fatality for uncomplicated strep throat, higher mortality with invasive forms, and geographic variation in reported rates.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Typical case fatality for uncomplicated strep throat | Very low with appropriate antibiotics | Public health surveillance |
| Risk of rheumatic fever in high-income regions | Low due to timely antibiotic use | Clinical guidelines |
| Invasive GAS case fatality (varies by region) | Elevated compared with non-invasive disease | Epidemiological studies |
| Key risk factor for poor outcomes | Delayed or absent treatment, comorbidities | Epidemiological studies |
| Common local complications if untreated | Peritonsillar abscess, cellulitis, sinusitis | Clinical literature |
Prevention and When to Seek Care
Good hygiene, covering coughs and sneezes, and avoiding close contact with infected individuals help limit spread. Completing prescribed antibiotic courses reduces complications and transmission. People with difficulty breathing, severe neck swelling, chest pain, confusion, persistent dizziness, or blueish lips require immediate medical attention. Ongoing care for recurrent episodes or complications should be coordinated with a clinician.